IDEXX LABORATORIES INC /DE 8-K

What Happened
IDEXX Laboratories filed an 8‑K reporting that at its May 12, 2026 annual meeting shareholders approved amendments to the Amended and Restated Certificate of Incorporation to (1) declassify the Board over a three‑year period so all directors will be elected annually beginning at the 2029 annual meeting and (2) give shareholders who own at least 25% of the company’s stock continuously for at least one year the right to request a special meeting (subject to additional terms in the By‑Laws). A Certificate of Amendment was filed with the Delaware Secretary of State and became effective May 13, 2026. The Board’s previously approved amendments to the By‑Laws were amended and restated effective upon that filing.

Key Details

• Annual meeting date: May 12, 2026; Certificate of Amendment filed and effective May 13, 2026.
• Declassification vote (Proposal 4): For 68,306,553; Against 61,880; Abstain 58,378; Broker non‑votes 4,524,699.
• Special‑meeting charter amendment (Proposal 5): For 63,934,239; Against 690,137; Abstain 3,802,435; Broker non‑votes 4,524,699. The right requires 25% ownership continuously for one year and is subject to by‑law terms and procedures.
• Shareholder proposal to give shareholders the ability to call a special meeting (Proposal 6) failed: For 28,179,566; Against 40,019,951; Abstain 227,294.
• Director elections and other votes: Daniel Junius, Lawrence Kingsley and Sophie Vandebroek were re‑elected as Class II directors; PwC was ratified as independent auditor; advisory “say on pay” vote passed.

Why It Matters
Declassifying the board moves IDEXX toward annual director elections (starting 2029), increasing shareholder influence over board composition on a yearly basis. The new special‑meeting right gives a large, long‑term holder (25% ownership for one year) a formal mechanism to call a meeting, but the high ownership threshold and by‑law conditions limit how broadly that power can be used. The failure of an alternative shareholder proposal on special meetings indicates shareholders preferred the company‑proposed terms. These governance changes can affect shareholder engagement and proxy dynamics going forward; they do not change company operations or financials disclosed in this filing.